The Childhood Cancer Blog
The Childhood Cancer Blog
![Elijah was diagnosed with neuroblastoma, the most common solid non-brain tumor in children, at just 4 years old. His diagnosis came in 2005, just a year after Alex Scott passed away. Elijah’s family repeated the difficult cycle of remission and relapse over the next three years.](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/elijah_5678.jpg?itok=jb3ESnge)
Elijah, now 17, is battling relapsed neuroblastoma.
After three years of treatment for neuroblastoma, Elijah Talley had exhausted options at his hometown hospital. Diagnosed when he was just 4 years old, Elijah went through the endless cycle of treatment and relapse, again and again. Conventional treatments, which included high dose chemotherapy, radiation and a stem cell transplant, failed.
Neuroblastoma, the most common type of extra-cranial solid tumor in children, can range from benign to malignant. Advances in targeted... Read More
![](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/img-5351.jpg?itok=zdC3GVbB)
SLA attendee Reilley Connelly with hero Brooke Mulford. Brooke inspired Reilley to get involved with ALSF and to stay involved.
Reilley Connelly, a sophomore at Boston University, is a two-time ALSF Student Leadership Academy attendee. Reilley first discovered the Student Leadership Academy (SLA) as a junior in high school. Then last year, when the program opened to college freshmen, sophomores and juniors, Reilley applied again.
“Before the Student Leadership Academy, I had no idea how powerful one person could be to make a difference in the world,” said Reilley. Now, Reilley is taking the lessons she learned at the SLA to... Read More
by Trish Adkins, ALSF
Breakthroughs and cures for childhood cancer are only possible through comprehensive, cutting-edge research performed by the best minds in pediatric oncology. Each year, Alex’s Lemonade Stand Foundation (ALSF) provides grants to these oncology superstars—ensuring the future of research will mean safer treatments and more cures for children.
Our grants program funds all phases of research—from early career and... Read More
Pages